Article
Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
Clinica chimica acta; international journal of clinical chemistry - 25 Sept 2014
Chang Ya-Sian, Er Tze-Kiong, Lu Hsiu-Chin, Yeh Kun-Tu, Chang Jan-Gowth
Abstract excerpt
BACKGROUND: The identification of KRAS mutations before the administration of anti-epidermal growth factor receptor (EGFR) therapy of metastatic colorectal cancer (mCRC) has become important. The aim of the present study was to develop a novel technology that can increase detection sensitivity for KRAS mutations. METHODS: DNAs were extracted from colorectal cancer tissues and formalin-fixed, paraffin-embedded...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
